Skip to main content
SpringerLink
Log in

Congenital Nephrotic Syndrome

  • Reference work entry
Pediatric Nephrology

Abstract

Renal diseases associated with nephrotic syndrome (NS) in the first year of life are uncommon and make up a heterogeneous group of disorders (1). Congenital nephrotic syndrome (CNS) is defined as proteinuria manifesting in the first 3 months of life. NS appearing later during the first year (4–12 months) is defined infantile, and NS manifesting thereafter is called childhood NS. While this classification is used to help the clinical diagnosis, it is arbitrary in the sense that NS caused by a specific gene mutation can manifest soon after birth or later in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 369.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol 1993;7(4):347–353.

    Article  PubMed  CAS  Google Scholar 

  2. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K et al. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007;119(4):e907–e919.

    Article  PubMed  Google Scholar 

  3. Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol 2004;19(12):1313–1318.

    Article  PubMed  Google Scholar 

  4. Tryggvason K, Patrakka J, Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 2006;354(13):1387–1401.

    Article  PubMed  CAS  Google Scholar 

  5. D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003;63(3):809–825.

    Article  PubMed  Google Scholar 

  6. Jalanko H, Patrakka J, Tryggvason K, Holmberg C. Genetic kidney diseases disclose the pathogenesis of proteinuria. Ann Med 2001;33(8):526–533.

    Article  PubMed  CAS  Google Scholar 

  7. Kawachi H, Miyauchi N, Suzuki K, Han GD, Orikasa M, Shimizu F. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton) 2006;11(4):274–281.

    Article  CAS  Google Scholar 

  8. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002;13(12):3005–3015.

    Article  PubMed  Google Scholar 

  9. Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest 2006;116(8):2272–2279.

    Article  PubMed  CAS  Google Scholar 

  10. Jalanko H. Pathogenesis of proteinuria: lessons learned from nephrin and podocin. Pediatr Nephrol 2003;18(6):487–491.

    PubMed  Google Scholar 

  11. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004;15(10):2611–2618.

    Article  PubMed  Google Scholar 

  12. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24(3):251–256.

    Article  PubMed  CAS  Google Scholar 

  13. Pollak MR. Focal segmental glomerulosclerosis: recent advances. Curr Opin Nephrol Hypertens 2008;17(2):138–142.

    Article  PubMed  Google Scholar 

  14. Yao J, Le TC, Kos CH, Henderson JM, Allen PG, Denker BM et al. Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol 2004;2(6):e167.

    Article  PubMed  Google Scholar 

  15. Holzman LB, St John PL, Kovari IA, Verma R, Holthofer H, Abrahamson DR. Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 1999;56(4):1481–1491.

    Article  PubMed  Google Scholar 

  16. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H et al. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998;1(4):575–582.

    Article  PubMed  CAS  Google Scholar 

  17. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999;96(14):7962–7967.

    Article  PubMed  CAS  Google Scholar 

  18. Wartiovaara J, Ofverstedt LG, Khoshnoodi J, Zhang J, Makela E, Sandin S et al. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 2004;114(10):1475–1483.

    PubMed  CAS  Google Scholar 

  19. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003;23(14):4917–4928.

    Article  PubMed  CAS  Google Scholar 

  20. Jones N, Blasutig IM, Eremina V, Ruston JM, Bladt F, Li H et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006;440(7085):818–823.

    Article  PubMed  CAS  Google Scholar 

  21. Zhu J, Sun N, Aoudjit L, Li H, Kawachi H, Lemay S et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int 2008;73(5):556–566.

    Article  PubMed  CAS  Google Scholar 

  22. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004;15(6):1382–1391.

    Article  PubMed  Google Scholar 

  23. Lehtonen S. Connecting the interpodocyte slit diaphragm and actin dynamics: Emerging role for the nephrin signaling complex. Kidney Int 2008;73(8):903–905.

    Article  PubMed  CAS  Google Scholar 

  24. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001;21(14):4829–4836.

    Article  PubMed  CAS  Google Scholar 

  25. Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001;59(3):1003–1012.

    Article  PubMed  CAS  Google Scholar 

  26. Barletta GM, Kovari IA, Verma RK, Kerjaschki D, Holzman LB. Nephrin and Neph1 co-localize at the podocyte foot process intercellular junction and form cis hetero-oligomers. J Biol Chem 2003;278(21):19266–19271.

    Article  PubMed  CAS  Google Scholar 

  27. Gerke P, Huber TB, Sellin L, Benzing T, Walz G. Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1. J Am Soc Nephrol 2003;14(4):918–926.

    Article  PubMed  CAS  Google Scholar 

  28. Sellin L, Huber TB, Gerke P, Quack I, Pavenstadt H, Walz G. NEPH1 defines a novel family of podocin interacting proteins. Faseb J 2003;17(1):115–117.

    PubMed  CAS  Google Scholar 

  29. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24(4):349–354.

    Article  PubMed  CAS  Google Scholar 

  30. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003;300(5623):1298–1300.

    Article  PubMed  CAS  Google Scholar 

  31. Patari-Sampo A, Ihalmo P, Holthofer H. Molecular basis of the glomerular filtration: nephrin and the emerging protein complex at the podocyte slit diaphragm. Ann Med 2006;38(7):483–492.

    Article  PubMed  CAS  Google Scholar 

  32. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 2002;160(1):131–139.

    Article  PubMed  CAS  Google Scholar 

  33. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001;108(11):1621–1629.

    PubMed  CAS  Google Scholar 

  34. Wolf G, Stahl RA. CD2-associated protein and glomerular disease. Lancet 2003;362(9397):1746–1748.

    Article  PubMed  CAS  Google Scholar 

  35. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T. Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001;276(45):41543–41546.

    Article  PubMed  CAS  Google Scholar 

  36. Ahvenainen EK, Hallman N, Hjelt L. Nephrotic syndrome in newborn and young infants. Ann Paediatr Fenn 1956;2(3):227–241.

    PubMed  CAS  Google Scholar 

  37. Norio R. Heredity in the congenital nephrotic syndrome. A genetic study of 57 finnish FAMILIES WITH A REVIEW OF REPORTED CASES. Ann Paediatr Fenn 1966;12(Suppl 27):1–94.

    PubMed  Google Scholar 

  38. Huttunen NP. Congenital nephrotic syndrome of Finnish type. Study of 75 patients. Arch Dis Child 1976;51(5):344–348.

    Article  PubMed  CAS  Google Scholar 

  39. Aya K, Tanaka H, Seino Y. Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type. Kidney Int 2000;57(2):401–404.

    Article  PubMed  CAS  Google Scholar 

  40. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K. Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 2001;17(5):368–373.

    Article  PubMed  CAS  Google Scholar 

  41. Bolk S, Puffenberger EG, Hudson J, Morton DH, Chakravarti A. Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am J Hum Genet 1999;65(6):1785–1790.

    Article  PubMed  CAS  Google Scholar 

  42. Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K et al. Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 2002;11(4):379–388.

    Article  PubMed  CAS  Google Scholar 

  43. Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999;64(1):51–61.

    Article  PubMed  CAS  Google Scholar 

  44. Gigante M, Monno F, Roberto R, Laforgia N, Assael MB, Livolti S et al. Congenital nephrotic syndrome of the Finnish type in Italy: a molecular approach. J Nephrol 2002;15(6):696–702.

    PubMed  CAS  Google Scholar 

  45. Heeringa SF, Vlangos CN, Chernin G, Hinkes B, Gbadegesin R, Liu J et al. Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol Dial Transplant 2008;23(11):3527–3533.

    Google Scholar 

  46. Patrakka J, Kestila M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U et al. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int 2000;58(3):972–980.

    Article  PubMed  CAS  Google Scholar 

  47. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001;10(1):1–8.

    Article  PubMed  CAS  Google Scholar 

  48. Liu L, Done SC, Khoshnoodi J, Bertorello A, Wartiovaara J, Berggren PO et al. Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum Mol Genet 2001;10(23):2637–2644.

    Article  PubMed  CAS  Google Scholar 

  49. Moeller MJ, Kovari IA, Holzman LB. Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 5′flanking region drives LacZ expression in podocytes. J Am Soc Nephrol 2000;11(12):2306–2314.

    PubMed  CAS  Google Scholar 

  50. Kuusniemi AM, Kestila M, Patrakka J, Lahdenkari AT, Ruotsalainen V, Holmberg C et al. Tissue expression of nephrin in human and pig. Pediatr Res 2004;55(5):774–781.

    Article  PubMed  CAS  Google Scholar 

  51. Rapola J, Savilahti E. Immunofluorescent and morphological studies in congenital nephrotic syndrome. Acta Paediatr Scand 1971;60(3):253–263.

    Article  PubMed  CAS  Google Scholar 

  52. Ruotsalainen V, Patrakka J, Tissari P, Reponen P, Hess M, Kestila M et al. Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol 2000;157(6):1905–1916.

    Article  PubMed  CAS  Google Scholar 

  53. Kwoh C, Shannon MB, Miner JH, Shaw A. Pathogenesis of nonimmune glomerulopathies. Annu Rev Pathol 2006;1:349–374.

    Article  PubMed  CAS  Google Scholar 

  54. Patrakka J, Martin P, Salonen R, Kestila M, Ruotsalainen V, Mannikko M et al. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations. Lancet 2002;359(9317):1575–1577.

    Article  PubMed  CAS  Google Scholar 

  55. Kuusniemi AM, Merenmies J, Lahdenkari AT, Holmberg C, Salmela K, Karikoski R et al. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1). Kidney Int 2006;70(8):1423–1431.

    Article  PubMed  CAS  Google Scholar 

  56. Kaukinen A, Kuusniemi AM, Lautenschlager I, Jalanko H. Glomerular endothelium in kidneys with congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrol Dial Transplant 2008;23(4):1224–1232.

    Article  PubMed  Google Scholar 

  57. Kuusniemi AM, Lapatto R, Holmberg C, Karikoski R, Rapola J, Jalanko H. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int 2005;68(1):121–132.

    Article  PubMed  CAS  Google Scholar 

  58. Holmberg C, Antikainen M, Ronnholm K, Ala Houhala M, Jalanko H. Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 1995;9(1):87–93.

    Article  PubMed  CAS  Google Scholar 

  59. Grech V, Chan MK, Vella C, Attard Montalto S, Rees P, Trompeter RS. Cardiac malformations associated with the congenital nephrotic syndrome. Pediatr Nephrol 2000;14(12):1115–1117.

    Article  PubMed  CAS  Google Scholar 

  60. Antikainen M, Holmberg C, Taskinen MR. Growth, serum lipoproteins and apoproteins in infants with congenital nephrosis. Clin Nephrol 1992;38(5):254–263.

    PubMed  CAS  Google Scholar 

  61. McLean RH, Kennedy TL, Rosoulpour M, Ratzan SK, Siegel NJ, Kauschansky A et al. Hypothyroidism in the congenital nephrotic syndrome. J Pediatr 1982;101(1):72–75.

    Article  PubMed  CAS  Google Scholar 

  62. Antikainen M, Sariola H, Rapola J, Taskinen MR, Holthofer H, Holmberg C. Pathology of renal arteries of dyslipidemic children with congenital nephrosis. Apmis 1994;102(2):129–134.

    Article  PubMed  CAS  Google Scholar 

  63. Aldamiz-Echevarria L, Vallo A, Aguirre M, Sanjurjo P, Gonzalez-Lamuno D, Elorz J et al. Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria. Pediatr Nephrol 2007;22(4):533–540.

    Article  PubMed  Google Scholar 

  64. Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004;66(2):571–579.

    Article  PubMed  CAS  Google Scholar 

  65. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12(12):2742–2746.

    PubMed  CAS  Google Scholar 

  66. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 2003;14(5):1278–1286.

    Article  PubMed  CAS  Google Scholar 

  67. Frishberg Y, Rinat C, Megged O, Shapira E, Feinstein S, Raas-Rothschild A. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 2002;13(2):400–405.

    PubMed  CAS  Google Scholar 

  68. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002;13(2):388–393.

    PubMed  CAS  Google Scholar 

  69. Ozcakar ZB, Cengiz FB, Cakar N, Uncu N, Kara N, Acar B et al. Analysis of NPHS2 mutations in Turkish steroid-resistant nephrotic syndrome patients. Pediatr Nephrol 2006;21(8):1093–1096.

    Article  PubMed  Google Scholar 

  70. Sako M, Nakanishi K, Obana M, Yata N, Hoshii S, Takahashi S et al. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int 2005;67(4):1248–1255.

    Article  PubMed  CAS  Google Scholar 

  71. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2008;19(2):365–371.

    Article  PubMed  Google Scholar 

  72. Nishibori Y, Liu L, Hosoyamada M, Endou H, Kudo A, Takenaka H et al. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int 2004;66(5):1755–1765.

    Article  PubMed  CAS  Google Scholar 

  73. Schultheiss M, Ruf RG, Mucha BE, Wiggins R, Fuchshuber A, Lichtenberger A et al. No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations. Pediatr Nephrol 2004;19(12):1340–1348.

    Article  PubMed  Google Scholar 

  74. Frishberg Y, Feinstein S, Rinat C, Becker-Cohen R, Lerer I, Raas-Rothschild A et al. The heart of children with steroid-resistant nephrotic syndrome: is it all podocin? J Am Soc Nephrol 2006;17(1):227–231.

    Article  PubMed  CAS  Google Scholar 

  75. Caridi G, Dagnino M, Carrea A, Massella L, Amore A, Emma F et al. Lack of cardiac anomalies in children with NPHS2 mutations. Nephrol Dial Transplant 2007;22(5):1477–1479.

    Article  PubMed  Google Scholar 

  76. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 1990;60(3):509–520.

    Article  PubMed  CAS  Google Scholar 

  77. Mrowka C, Schedl A. Wilms’ tumor suppressor gene WT1: from structure to renal pathophysiologic features. J Am Soc Nephrol 2000;11(Suppl 16):S106–115.

    PubMed  CAS  Google Scholar 

  78. Stoll R, Lee BM, Debler EW, Laity JH, Wilson IA, Dyson HJ et al. Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA. J Mol Biol 2007;372(5):1227–1245.

    Article  PubMed  CAS  Google Scholar 

  79. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol 2006;21(11):1653–1660.

    Article  PubMed  Google Scholar 

  80. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997;17(4):467–470.

    Article  PubMed  CAS  Google Scholar 

  81. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P et al. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/−KTS splice isoforms. Hum Mol Genet 1998;7(4):709–714.

    Article  PubMed  CAS  Google Scholar 

  82. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990;343(6260):774–778.

    Article  PubMed  CAS  Google Scholar 

  83. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67(2):437–447.

    Article  PubMed  CAS  Google Scholar 

  84. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 1997;9(3):209–225.

    Article  PubMed  CAS  Google Scholar 

  85. Schumacher V, Scharer K, Wuhl E, Altrogge H, Bonzel KE, Guschmann M et al. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 1998;53(6):1594–1600.

    Article  PubMed  CAS  Google Scholar 

  86. Natoli TA, Liu J, Eremina V, Hodgens K, Li C, Hamano Y et al. A mutant form of the Wilms’ tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 2002;13(8):2058–2067.

    Article  PubMed  CAS  Google Scholar 

  87. Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 1999;154(1):181–192.

    Article  PubMed  CAS  Google Scholar 

  88. Guo JK, Menke AL, Gubler MC, Clarke AR, Harrison D, Hammes A et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 2002;11(6):651–659.

    Article  PubMed  CAS  Google Scholar 

  89. Denys P, Malvaux P, Van Den Berghe H, Tanghe W, Proesmans W. [Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms’ tumor, parenchymatous nephropathy and XX/XY mosaicism]. Arch Fr Pediatr 1967;24(7):729–739.

    PubMed  CAS  Google Scholar 

  90. Drash A, Sherman F, Hartmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J Pediatr 1970;76(4):585–593.

    Article  PubMed  CAS  Google Scholar 

  91. Barakat AY, Papadopoulou ZL, Chandra RS, Hollerman CE, Calcagno PL. Pseudohermaphroditism, nephron disorder and wilms’ tumor: a unifying concept. Pediatrics 1974;54(3):366–369.

    PubMed  CAS  Google Scholar 

  92. Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993;123(5):673–678.

    Article  PubMed  CAS  Google Scholar 

  93. Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M et al. The nephropathy associated with male pseudohermaphroditism and Wilms’ tumor (Drash syndrome): a distinctive glomerular lesion – report of 10 cases. Clin Nephrol 1985;24(6):269–278.

    PubMed  CAS  Google Scholar 

  94. Hu M, Zhang GY, Arbuckle S, Graf N, Shun A, Silink M et al. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene. Nephrol Dial Transplant 2004;19(1):223–226.

    Article  PubMed  CAS  Google Scholar 

  95. Hahn H, Cho YM, Park YS, You HW, Cheong HI. Two cases of isolated diffuse mesangial sclerosis with WT1 mutations. J Korean Med Sci 2006;21(1):160–164.

    Article  PubMed  CAS  Google Scholar 

  96. Ismaili K, Verdure V, Vandenhoute K, Janssen F, Hall M. WT1 gene mutations in three girls with nephrotic syndrome. Eur J Pediatr 2008;167(5):579–581.

    Article  PubMed  Google Scholar 

  97. Ito S, Takata A, Hataya H, Ikeda M, Kikuchi H, Hata J et al. Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene. J Pediatr 2001;138(3):425–427.

    Article  PubMed  CAS  Google Scholar 

  98. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A et al. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 1998;62(4):824–833.

    Article  PubMed  CAS  Google Scholar 

  99. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B et al. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 2004;66(2):564–570.

    Article  PubMed  CAS  Google Scholar 

  100. Martul EV, Cuesta MG, Churg I. Histopathologic variability of the congenital nephrotic syndrome. Clin Nephrol 1987;28(4):161–168.

    PubMed  CAS  Google Scholar 

  101. Matejas V, Al-Gazali L, Amirlak I, Zenker M. A syndrome comprising childhood-onset glomerular kidney disease and ocular abnormalities with progressive loss of vision is caused by mutated LAMB2. Nephrol Dial Transplant 2006;21(11):3283–3286.

    Article  PubMed  CAS  Google Scholar 

  102. VanDeVoorde R, Witte D, Kogan J, Goebel J. Pierson syndrome: a novel cause of congenital nephrotic syndrome. Pediatrics 2006;118(2):e501–5.

    Article  PubMed  Google Scholar 

  103. Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 2004;13(21):2625–2632.

    Article  PubMed  CAS  Google Scholar 

  104. Zenker M, Tralau T, Lennert T, Pitz S, Mark K, Madlon H et al. Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: an autosomal recessive syndrome. Am J Med Genet A 2004;130A(2):138–145.

    Article  PubMed  Google Scholar 

  105. Wuhl E, Kogan J, Zurowska A, Matejas V, Vandevoorde RG, Aigner T et al. Neurodevelopmental deficits in Pierson (microcoria-congenital nephrosis) syndrome. Am J Med Genet A 2007;143(4):311–319.

    PubMed  Google Scholar 

  106. Hasselbacher K, Wiggins RC, Matejas V, Hinkes BG, Mucha B, Hoskins BE et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int 2006;70(6):1008–1012.

    Article  PubMed  CAS  Google Scholar 

  107. Kagan M, Cohen AH, Matejas V, Vlangos C, Zenker M. A milder variant of Pierson syndrome. Pediatr Nephrol 2008;23(2):323–327.

    Article  PubMed  Google Scholar 

  108. Choi HJ, Lee BH, Kang JH, Jeong HJ, Moon KC, Ha IS et al. Variable phenotype of Pierson syndrome. Pediatr Nephrol 2008.

    Google Scholar 

  109. Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 2006;38(12):1397–1405.

    Article  PubMed  CAS  Google Scholar 

  110. Jefferson JA, Shankland SJ. Familial nephrotic syndrome: PLCE1 enters the fray. Nephrol Dial Transplant 2007;22(7):1849–1852.

    Article  PubMed  Google Scholar 

  111. Chaib H, Hoskins BE, Ashraf S, Goyal M, Wiggins RC, Hildebrandt F. Identification of BRAF as a new interactor of PLCepsilon1, the protein mutated in nephrotic syndrome type 3. Am J Physiol Renal Physiol 2008;294(1):F93–99.

    Article  PubMed  CAS  Google Scholar 

  112. Hinkes BG. NPHS3: new clues for understanding idiopathic nephrotic syndrome. Pediatr Nephrol 2008.

    Google Scholar 

  113. Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J et al. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 2008;23(4):1291–1297.

    Article  PubMed  CAS  Google Scholar 

  114. Galloway WH, Mowat AP. Congenital microcephaly with hiatus hernia and nephrotic syndrome in two sibs. J Med Genet 1968;5(4):319–321.

    Article  PubMed  CAS  Google Scholar 

  115. Srivastava T, Whiting JM, Garola RE, Dasouki MJ, Ruotsalainen V, Tryggvason K et al. Podocyte proteins in Galloway-Mowat syndrome. Pediatr Nephrol 2001;16(12):1022–1029.

    Article  PubMed  CAS  Google Scholar 

  116. Garty BZ, Eisenstein B, Sandbank J, Kaffe S, Dagan R, Gadoth N. Microcephaly and congenital nephrotic syndrome owing to diffuse mesangial sclerosis: an autosomal recessive syndrome. J Med Genet 1994;31(2):121–125.

    Article  PubMed  CAS  Google Scholar 

  117. Nishikawa M, Ichiyama T, Hayashi T, Furukawa S. A case of early myoclonic encephalopathy with the congenital nephrotic syndrome. Brain Dev 1997;19(2):144–147.

    Article  PubMed  CAS  Google Scholar 

  118. Barakat AY, D’Albora JB, Martin MM, Jose PA. Familial nephrosis, nerve deafness, and hypoparathyroidism. J Pediatr 1977;91(1):61–64.

    Article  PubMed  CAS  Google Scholar 

  119. Meyers KE, Kaplan P, Kaplan BS. Nephrotic syndrome, microcephaly, and developmental delay: three separate syndromes. Am J Med Genet 1999;82(3):257–260.

    Article  PubMed  CAS  Google Scholar 

  120. Sano H, Miyanoshita A, Watanabe N, Koga Y, Miyazawa Y, Yamaguchi Y et al. Microcephaly and early-onset nephrotic syndrome – confusion in Galloway-Mowat syndrome. Pediatr Nephrol 1995;9(6):711–714.

    Article  PubMed  CAS  Google Scholar 

  121. Yalcinkaya F, Tumer N, Ekim M, Kuyucu S, Cakar N, Ensari C. Congenital microcephaly and infantile nephrotic syndrome – a case report. Pediatr Nephrol 1994;8(1):72–73.

    Article  PubMed  CAS  Google Scholar 

  122. Mildenberger E, Lennert T, Kunze J, Jandeck C, Waldherr R, Versmold H. Diffuse mesangial sclerosis: association with unreported congenital anomalies and placental enlargement. Acta Paediatr 1998;87(12):1301–1303.

    Article  PubMed  CAS  Google Scholar 

  123. Opitz JM, Lowry RB, Holmes TM, Morgan K. Hutterite cerebro-osteo-nephrodysplasia: autosomal recessive trait in a Lehrerleut Hutterite family from Montana. Am J Med Genet 1985;22(3):521–529.

    Article  PubMed  CAS  Google Scholar 

  124. Bongers EM, Gubler MC, Knoers NV. Nail-patella syndrome. Overview on clinical and molecular findings. Pediatr Nephrol 2002;17(9):703–712.

    Article  PubMed  Google Scholar 

  125. Heidet L, Bongers EM, Sich M, Zhang SY, Loirat C, Meyrier A et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am J Pathol 2003;163(1):145–155.

    Article  PubMed  CAS  Google Scholar 

  126. Lemley KV. Kidney disease in nail-patella syndrome. Pediatr Nephrol 2008. June 6(EPub ahead of print).

    Google Scholar 

  127. Nielsen KF, Steffensen GK. Congenital nephrotic syndrome associated with Lowe’s syndrome. Child Nephrol Urol 1990;10(2):92–95.

    PubMed  CAS  Google Scholar 

  128. Hata D, Miyazaki M, Seto S, Kadota E, Muso E, Takasu K et al. Nephrotic syndrome and aberrant expression of laminin isoforms in glomerular basement membranes for an infant with Herlitz junctional epidermolysis bullosa. Pediatrics 2005;116(4):e601–7.

    Article  PubMed  Google Scholar 

  129. Sperl W, Gruber W, Quatacker J, Monnens L, Thoenes W, Fink FM et al. Nephrosis in two siblings with infantile sialic acid storage disease. Eur J Pediatr 1990;149(7):477–482.

    Article  PubMed  CAS  Google Scholar 

  130. Goldenberg A, Ngoc LH, Thouret MC, Cormier-Daire V, Gagnadoux MF, Chretien D et al. Respiratory chain deficiency presenting as congenital nephrotic syndrome. Pediatr Nephrol 2005;20(4):465–469.

    PubMed  Google Scholar 

  131. Hameed R, Raafat F, Ramani P, Gray G, Roper HP, Milford DV. Mitochondrial cytopathy presenting with focal segmental glomerulosclerosis, hypoparathyroidism, sensorineural deafness, and progressive neurological disease. Postgrad Med J 2001;77(910):523–526.

    Article  PubMed  CAS  Google Scholar 

  132. Martin-Hernandez E, Garcia-Silva MT, Vara J, Campos Y, Cabello A, Muley R et al. Renal pathology in children with mitochondrial diseases. Pediatr Nephrol 2005;20(9):1299–1305.

    Article  PubMed  Google Scholar 

  133. Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 2005;65(4):606–608.

    Article  PubMed  CAS  Google Scholar 

  134. Niemsiri S. Congenital syphilitic nephrosis. Southeast Asian J Trop Med Public Health 1993;24(3):595–600.

    PubMed  CAS  Google Scholar 

  135. Vachvanichsanong P, Mitarnun W, Tungsinmunkong K, Dissaneewate P. Congenital and infantile nephrotic syndrome in Thai infants. Clin Pediatr (Phila) 2005;44(2):169–174.

    Article  Google Scholar 

  136. Basker M, Agarwal I, Bendon KS. Congenital nephrotic syndrome-a treatable cause. Ann Trop Paediatr 2007;27(1):87–90.

    Article  PubMed  Google Scholar 

  137. Batisky DL, Roy S, 3rd, Gaber LW. Congenital nephrosis and neonatal cytomegalovirus infection: a clinical association. Pediatr Nephrol 1993;7(6):741–743.

    Article  PubMed  CAS  Google Scholar 

  138. Besbas N, Bayrakci US, Kale G, Cengiz AB, Akcoren Z, Akinci D et al. Cytomegalovirus-related congenital nephrotic syndrome with diffuse mesangial sclerosis. Pediatr Nephrol 2006;21(5):740–742.

    Article  PubMed  Google Scholar 

  139. Shahin B, Papadopoulou ZL, Jenis EH. Congenital nephrotic syndrome associated with congenital toxoplasmosis. J Pediatr 1974;85(3):366–370.

    Article  PubMed  CAS  Google Scholar 

  140. Esterly JR, Oppenheimer EH. Pathological lesions due to congenital rubella. Arch Pathol 1969;87(4):380–388.

    PubMed  CAS  Google Scholar 

  141. Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 2002;13(12):2997–3004.

    Article  PubMed  Google Scholar 

  142. Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 1994;8(1):11–14.

    Article  PubMed  CAS  Google Scholar 

  143. Dudley J, Fenton T, Unsworth J, Chambers T, MacIver A, Tizard J. Systemic lupus erythematosus presenting as congenital nephrotic syndrome. Pediatr Nephrol 1996;10(6):752–755.

    Article  PubMed  CAS  Google Scholar 

  144. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002;346(26):2053–2060.

    Article  PubMed  Google Scholar 

  145. Nortier JL, Debiec H, Tournay Y, Mougenot B, Noel JC, Deschodt-Lanckman MM et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol 2006;21(10):1399–1405.

    Article  PubMed  Google Scholar 

  146. Aula P, Rapola J, Karjalainen O, Lindgren J, Hartikainen AL, Seppala M. Prenatal diagnosis of congenital nephrosis in 23 high-risk families. Am J Dis Child 1978;132(10):984–987.

    PubMed  CAS  Google Scholar 

  147. Flynn JT, Schulman SL, deChadarevian JP, Dunn SP, Kaiser BA, Polinsky MS et al. Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. Pediatr Nephrol 1992;6(6):553–555.

    Article  PubMed  CAS  Google Scholar 

  148. Kovacevic L, Reid CJ, Rigden SP. Management of congenital nephrotic syndrome. Pediatr Nephrol 2003;18(5):426–430.

    PubMed  Google Scholar 

  149. Savage JM, Jefferson JA, Maxwell AP, Hughes AE, Shanks JH, Gill D. Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Arch Dis Child 1999;80(5):466–469.

    Article  PubMed  CAS  Google Scholar 

  150. Guez S, Giani M, Melzi ML, Antignac C, Assael BM. Adequate clinical control of congenital nephrotic syndrome by enalapril. Pediatr Nephrol 1998;12(2):130–132.

    Article  PubMed  CAS  Google Scholar 

  151. Heaton PA, Smales O, Wong W. Congenital nephrotic syndrome responsive to captopril and indometacin. Arch Dis Child 1999;81(2):174–175.

    Article  PubMed  CAS  Google Scholar 

  152. Pomeranz A, Wolach B, Bernheim J, Korzets Z, Bernheim J. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. J Pediatr 1995;126(1):140–142.

    Article  PubMed  CAS  Google Scholar 

  153. Copelovitch L, Guttenberg M, Pollak MR, Kaplan BS. Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS. Pediatr Nephrol 2007;22(10):1779–1784.

    Article  PubMed  Google Scholar 

  154. Litwin M, Grenda R, Sladowska J, Antoniewicz J. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 2006;21(11):1716–1722.

    Article  PubMed  Google Scholar 

  155. Chadha V, Alon US. Bilateral nephrectomy reverses hypothyroidism in congenital nephrotic syndrome. Pediatr Nephrol 1999;13(3):209–211.

    Article  PubMed  CAS  Google Scholar 

  156. Gavin LA, McMahon FA, Castle JN, Cavalieri RR. Alterations in serum thyroid hormones and thyroxine-binding globulin in patients with nephrosis. J Clin Endocrinol Metab 1978;46(1):125–130.

    Article  PubMed  CAS  Google Scholar 

  157. Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G et al. Comprehensive study of haemostasis in nephrotic syndrome. Nephron 1983;33(1):9–13.

    Article  PubMed  CAS  Google Scholar 

  158. Llach F, Papper S, Massry SG. The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med 1980;69(6):819–827.

    Article  PubMed  CAS  Google Scholar 

  159. Mathias R, Stecklein H, Guay-Woodford L, Harmon WE, Harris HW, Jr. Gamma globulin deficiency in newborns with congenital nephrotic syndrome. N Engl J Med 1989;320(6):398–399.

    Article  PubMed  CAS  Google Scholar 

  160. Ljungberg P, Holmberg C, Jalanko H. Infections in infants with congenital nephrosis of the Finnish type. Pediatr Nephrol 1997;11(2):148–152.

    Article  PubMed  CAS  Google Scholar 

  161. Coulthard MG. Management of Finnish congenital nephrotic syndrome by unilateral nephrectomy. Pediatr Nephrol 1989;3(4):451–453.

    Article  PubMed  CAS  Google Scholar 

  162. Mattoo TK, al-Sowailem AM, al-Harbi MS, Mahmood MA, Katawee Y, Hassab MH. Nephrotic syndrome in 1st year of life and the role of unilateral nephrectomy. Pediatr Nephrol 1992;6(1):16–18.

    Article  PubMed  CAS  Google Scholar 

  163. Antikainen M. Protein and lipid metabolism in nephrotic infants on peritoneal dialysis after nephrectomy. Pediatr Nephrol 1993;7(4):428–433.

    Article  PubMed  CAS  Google Scholar 

  164. Holtta T, Happonen JM, Ronnholm K, Fyhrquist F, Holmberg C. Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatr Nephrol 2001;16(4):324–331.

    Article  PubMed  CAS  Google Scholar 

  165. Holtta T, Ronnholm K, Jalanko H, Holmberg C. Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol 2000;14(10–11):889–897.

    Article  PubMed  CAS  Google Scholar 

  166. Laakkonen H, Holtta T, Lonnqvist T, Holmberg C, Ronnholm K. Peritoneal dialysis in children under two years of age. Nephrol Dial Transplant 2008;23(5):1747–1753.

    Article  PubMed  Google Scholar 

  167. Salvatierra O, Jr., Sarwal M. Renal perfusion in infant recipients of adult-sized kidneys is a critical risk factor. Transplantation 2000;70(3):412–413.

    Article  PubMed  Google Scholar 

  168. Kuusniemi AM, Qvist E, Sun Y, Patrakka J, Ronnholm K, Karikoski R et al. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation 2007;83(10):1316–1323.

    Article  PubMed  Google Scholar 

  169. Becker-Cohen R, Bruschi M, Rinat C, Feinstein S, Zennaro C, Ghiggeri GM et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 2007;7(1):256–260.

    Article  PubMed  CAS  Google Scholar 

  170. Qvist E, Laine J, Ronnholm K, Jalanko H, Leijala M, Holmberg C. Graft function 5–7 years after renal transplantation in early childhood. Transplantation 1999;67(7):1043–1049.

    Article  PubMed  CAS  Google Scholar 

  171. Benfield MR, McDonald RA, Bartosh S, Ho PL, Harmon W. Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2003;7(4):321–335.

    Article  PubMed  Google Scholar 

  172. Qvist E, Krogerus L, Ronnholm K, Laine J, Jalanko H, Holmberg C. Course of renal allograft histopathology after transplantation in early childhood. Transplantation 2000;70(3):480–487.

    Article  PubMed  CAS  Google Scholar 

  173. Qvist E, Marttinen E, Ronnholm K, Antikainen M, Jalanko H, Sipila I et al. Growth after renal transplantation in infancy or early childhood. Pediatr Nephrol 2002;17(6):438–443.

    Article  PubMed  Google Scholar 

  174. Qvist E, Pihko H, Fagerudd P, Valanne L, Lamminranta S, Karikoski J et al. Neurodevelopmental outcome in high-risk patients after renal transplantation in early childhood. Pediatr Transplant 2002;6(1):53–62.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Hannu Jalanko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christer Holmberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical College of Wisconsin, Wisconsin, USA

    Ellis Avner (Director, Children's Research Institute, CHHS, Associate Dean for Research, Professor of Pediatrics and Physiology) (Director, Children's Research Institute, CHHS, Associate Dean for Research, Professor of Pediatrics and Physiology)

  2. Harvard Medical School, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts, 02115, USA

    William Harmon (Professor of Pediatrics, Director, Pediatric Nephrology) (Professor of Pediatrics, Director, Pediatric Nephrology)

  3. Service de Néphrologie Pédiatrique Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Hôpital Necker‐Enfants Malades, 149, rue de Sèvres, 75743, Paris Cedex 15, France

    Patrick Niaudet

  4. Department of Pediatrics Wakayama Medical University, Wakayama Medical University Hospital, 641–8510811–1, Kimiidera, Wakayama City, Japan

    Norishige Yoshikawa (Professor and Chair Pediatrician‐in‐Chief) (Professor and Chair Pediatrician‐in‐Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Jalanko, H., Holmberg, C. (2009). Congenital Nephrotic Syndrome. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-76341-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-76341-3_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-76327-7

  • Online ISBN: 978-3-540-76341-3

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation